Celecoxib vs Nivolumab

Celecoxib vs Nivolumab: Overview

This comparison examines the pharmacological differences between Celecoxib and Nivolumab.

Mechanism of Action

Celecoxib: Selective COX-2 inhibitor.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Celecoxib — 11 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Celecoxib — C17H14F3N3O2S.

Molecular Weight: Celecoxib — 381.3730 g/mol.

Type: Celecoxib — Small molecule; Nivolumab — Antibody.